Publications by authors named "Berit Maria Pfitzner"

Claim this Profile
T
The landscape of genetic aberrations in myxofibrosarcoma.
Yasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, Annegret Kunitz, Hiromichi Suzuki, Berit Maria Pfitzner

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Paul Jank, Judith Lea Lindner, Annika Lehmann, Berit Maria Pfitzner, Jens-Uwe Blohmer

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two case reports: Breast schwannoma and a rare case of an axillary schwannoma imitating an axillary lymph node metastasis.
Martin Duehrkoop, Bernd Frericks, Christine Ankel, Christine Boettcher, Wolfgang Hartmann, Berit Maria Pfitzner

Radiol Case Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience.
Jana Käthe Striefler, Franziska Brandes, Alexander Baur, Berit Maria Pfitzner, David Kaul

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Philipp Jurmeister, Anne Schöler, Alexander Arnold, Frederick Klauschen, Dido Lenze, Berit Maria Pfitzner

Mod Pathol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor.
Sibylle Loibl, Karsten Weber, Jens Huober, Kristin Krappmann, Frederik Marmé, Berit Maria Pfitzner

Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients.
Irène Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein

Oncotarget· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK expression as a prognostic and predictive marker in breast cancer.
Berit Maria Pfitzner, Daniel Branstetter, Sibylle Loibl, Carsten Denkert, Bianca Lederer

Breast Cancer Res Treat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis